Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs

Research in Veterinary Science

Volumn 68, Issue 3, 2000, Pages 211-216

  Lindecrona, R H ^b   Friis, C ^a   Nielsen, J P ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DANOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL SALMONELLOSIS; ANIMAL TISSUE; ARTICLE; CECUM; COLON; CONTROLLED STUDY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG PENETRATION; DRUG TISSUE LEVEL; GASTROINTESTINAL TRACT; HALF LIFE TIME; LYMPH NODE; NONHUMAN; SALMONELLA TYPHIMURIUM; SMALL INTESTINE; SWINE DISEASE;

EID: 0033944156     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1053/rvsc.1999.0361     Document Type: Article

References (24)

1. AGERSØ H. (1996) Pharmacokinetics and tissue penetration of amoxicillin in Actinobacillus pleuropneumoniae and Salmonella typhimurium infected pigs. Ph.D. thesis. Royal Veterinary & Agricultural University, Copenhagen, Denmark
2. APLEY M D. & UPSON D. W. (1993a) Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia. American Journal of Veterinary Research 54, 937-943
3. APLEY M.D. & UPSON D W. (1993b) Regional danofloxacin lung tissue concentrations and their relationship to regional pulmonary blood flow in consolidated and nonconsolidated bovine lung. American Journal of Veterinary Research 54, 944-951
4. BLATTEIS C.M., HALES J.R., FAWCETT A.A. & MASHBURN T.A. (1988) Fever and regional blood flows in wethers and parturient ewes. Journal of Applied Physiology 65, 165-172
5. DORFMAN M. BARSANTI J. & BUDSBERG S.C. (1995) Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis. American Journal of Veterinary Research 56, 386-390
6. FRIIS C. (1992) Penetration of danofloxacin into tissues of the respiratory tract and gastrointestinal tract in calves. XVII World Buiatrics Congress, Minnesota, USA Vol. 1, 102-107
7. FRIIS C. (1993) Penetration of danofloxacin into the respiratory tract tissue and secretions in calves. American Journal of Veterinary Research 54, 1122-1127
8. FRIIS C. & NIELSEN J.P. (1997) Penetration of danofloxacin into the respiratory tract tissues and secretions in healthy and in Actinobacillus pleuropneumoniae infected pigs. Proceedings of the 7th EAVPT Congress, Madrid, Spain. Journal of Veterinary Pharmacology and Therapeutics 20, suppl. 1, 108-109
9. GIBALDI M. & PERRIER D. (1982) Pharmacokinetics, 2nd ed. Pp. 409-417. Marcel Dekker, Inc., New York
10. GILES C.J., MAGONIGLE R.A., GRIMSHAW W.T.R., TANNER A.C., RISK J.E., LYNCH M.J. & RICE J.R. (1991) Clinical pharmacokinetics of parenterally admin strated danofloxacin in cattle. Journal of Veterinary Pharmacology and Therapeutics 14, 400-410
11. HALL W.F., EURELL T.E., HANSEN R.D. & HERR L.G. (1992) Serum hepatoglobin concentration in swine naturally infected o experimentally infected with Actinobacillus pleuropneumoniae. Journal of American Veterinary Medical Association 201, 1730-1733
12. MANN D.D. & FRAME G M (1992) Pharmacokinetic study of danofloxacin in cattle and swine. American Journal of Veterinary Research 53, 1022-1026
13. McKELLAR Q.A., GIBSCN I.F. & McCORMACK R.Z. (1998) Pharmacokinetics and tissue disposition of danofloxacin in sheep Biopharmaceutics and Drug Disposition 19. 123-129
14. MONSHOUWER M., WITKAMP R.F., NIJMEIER S.M., VAN LEENGOED L.A., VERHEIJDEN J.H. & VAN MIERT S.A. (1995a) Infection (Actinobacilius pleuropneumoniae) -mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs. Drug Metabolism and Disposition 23, 44-47
15. MONSHOUWER M., WITKAMP R.F., NIJMEIER S.M., PIJPERS A., VERHEIJDEN J.H. & VAN MIERT S.A. (1995b) Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol and indocyanine green in the pig. Xenobiotica 25, 491-499
16. RABBAA L., DAUTREY S., COLAS-LINHART N., CARBON C. & FARINOTTI R. (1996) Intestinal elimination of ofloxacin enantiomers in the rat: Evidence of a carrier-mediated process. Antimicrobial Agents and Chemotherapy 40, 2126-2130
17. RAEMDONCK D.L., TANNER A.C., TOLLING S.T. & MICHENER S.L. (1994) Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella nniltocida and Salmonella choleraesuis isolates from pigs. Veterinary Record 134, 5-7
18. RAMON J., DAUTREY S., FARINOTI R., CARBON C. & RUBINSTEIN E. (1994) Intestinal elimination of ciprofloxacin in rabbits. Antimicrobial Agents and Chemotherapy 38, 757-760
19. ROY R.B., SHAW R.W. & CONNELL G.E. (1969) A simple method for the determination of serum haptoglobin. Journal of Laboratory and Clinical Medicine 74, 698-704
20. SALMON S.A., WATTS J.L., CASE C.A., HOFFMAN L.J., WEGENER H.C. & YANCEY R.J. (1995) Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada and Denmark. Journal of Clinical Microbiology 33, 2435-2444
21. SCHEER M. & DE JONG A. (1997) Concentrations of fluoroquinolones in intestinal tract tissues after intramuscular administration to calves. Proceedings of the 7th EAVPT Congress, Madrid, Spain. Journal of Veterinary Pharmacology and Therapeutics 20, 50-51
22. THADEPALLI H., CHUAH S.K., THADEPALLI C.D. & MANDAL A.K. (1991) Antimicrobial activity of intravenous quinolones on the intestinal microflora in dogs. Chemotherapy 91, 6-14
23. VAN MIERT A.S.J.P.A.M. (1990) Influence of febrile disease on the pharmacokinetics of veterinary drugs. Annales de Recherches Vétérinaires 21, 11s-28s
24. WOLFSON, J.S. & HOOPER, D.C. (1985) The fluoroquinolones: Structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 28, 581-586